Trial intelligence / Profile preview

Methotrexate versus hydroxychloroquine for lichen planopilaris

IRCT2015062822959N1Phase 2Unknown

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of methotrexate and hydroxychloroquine in lichen planopilaris (LPP) (2 arms), sponsored by Isfahan University of Medical Sciences. Status: unknown.

02

Drugs

methotrexatehydroxychloroquine
03

Conditions

lichen planopilaris (LPP)

Beyond the preview

Go deeper on IRCT2015062822959N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015062822959N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call